Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Nebulized RNS60 for the Treatment of Amyotrophic Lateral Sclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02988297
Recruitment Status : Not yet recruiting
First Posted : December 9, 2016
Last Update Posted : September 2, 2019
Sponsor:
Information provided by (Responsible Party):
Revalesio Corporation

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : July 2022
Estimated Study Completion Date : July 2022